dimethyl 4-aminopimelate | 873843-61-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: dimethyl 4-aminopimelate
• 英文别名: 4-amino-heptanedioic acid dimethyl ester；Dimethyl 4-aminoheptanedioate
• CAS: 873843-61-9
• 化学式: C₉H₁₇NO₄
• 分子量: 203.238
• InChiKey: BXDJJTYLTIDMDL-UHFFFAOYSA-N

物化性质

• 沸点：
  282.7±35.0 °C(Predicted)
• 密度：
  1.080±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  14
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  78.6
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  dimethyl 4-aminopimelate 在 sodium hydroxide 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 反应 3.0h， 生成 4-((tert-butoxycarbonyl)amino)heptanedioic acid
  参考文献：
  名称：

  Branched Coordination Multilayers on Gold

  摘要：

  AC(3)-symmetric tridentate hexahydroxamate ligand molecule was specially synthesized and used for coordination self-assembly of branched multilayers on Au surfaces precoated with a self-assembled monolayer (SAM) of ligand anchors. Layer-by-layer (LbL) growth of multilayers via metal-organic coordination using Zr4+ ions proceeds with high regularity, adding one molecular layer in each step, as shown by ellipsometry, wettability, UV-vis spectroscopy, and atomic force microscopy (AFM). The branched multilayer films display improved stiffness, as well as a unique defect self-repair capability, attributed to cross-linking in the layers and lateral expansion over defects during multilayer growth. Transmetalation, i.e., exposure of Zr4+-based assemblies to Hf4+ ions, was used to evaluate the cross-linking. Conductive atomic force microscopy (AFM) was used to probe the electrical properties of the multilayers, revealing excellent dielectric behavior. The special properties of the branched layers were emphasized by comparison with analogous multilayers prepared similarly using linear (tetrahydroxamate) ligand molecules. The process of defect annihilation by bridging over defective areas, attributed to lateral expansion via the excess bishydroxamate groups, was demonstrated by introduction of artificial defects in the anchor monolayer, followed by assembly of two layers of either the linear or the branched molecule. Analysis of selective binding of Au nanoparticles (NIPS) to unblocked defects emphasized the superior repair mechanism in the branched layers with respect to the linear ones.

  DOI：

  10.1021/ja0556676
• 作为产物：
  描述：

  4-酮庚二酸 在 氯化亚砜 、 sodium cyanoborohydride 、 氯化铵 作用下， 以 甲醇 为溶剂， 反应 48.0h， 生成 dimethyl 4-aminopimelate
  参考文献：
  名称：

  Branched Coordination Multilayers on Gold

  摘要：

  AC(3)-symmetric tridentate hexahydroxamate ligand molecule was specially synthesized and used for coordination self-assembly of branched multilayers on Au surfaces precoated with a self-assembled monolayer (SAM) of ligand anchors. Layer-by-layer (LbL) growth of multilayers via metal-organic coordination using Zr4+ ions proceeds with high regularity, adding one molecular layer in each step, as shown by ellipsometry, wettability, UV-vis spectroscopy, and atomic force microscopy (AFM). The branched multilayer films display improved stiffness, as well as a unique defect self-repair capability, attributed to cross-linking in the layers and lateral expansion over defects during multilayer growth. Transmetalation, i.e., exposure of Zr4+-based assemblies to Hf4+ ions, was used to evaluate the cross-linking. Conductive atomic force microscopy (AFM) was used to probe the electrical properties of the multilayers, revealing excellent dielectric behavior. The special properties of the branched layers were emphasized by comparison with analogous multilayers prepared similarly using linear (tetrahydroxamate) ligand molecules. The process of defect annihilation by bridging over defective areas, attributed to lateral expansion via the excess bishydroxamate groups, was demonstrated by introduction of artificial defects in the anchor monolayer, followed by assembly of two layers of either the linear or the branched molecule. Analysis of selective binding of Au nanoparticles (NIPS) to unblocked defects emphasized the superior repair mechanism in the branched layers with respect to the linear ones.

  DOI：

  10.1021/ja0556676

文献信息

• [EN] 4-PHENOXY-NICOTINAMIDE OR 4-PHENOXY-PYRIMIDINE-5-CARBOXAMIDE COMPOUNDS<br/>[FR] COMPOSÉS DE 4-PHÉNOXYNICOTINAMIDE OU DE 4-PHÉNOXY-PYRIMIDINE-5-CARBOXAMIDE
  申请人：HOFFMANN LA ROCHE

  公开号：WO2011089099A1

  公开（公告）日：2011-07-28

  This invention relates to novel phenyl amide or pyridyl amide derivatives of the formula (I), wherein A1, A2, B1, B2 and R1 to R11 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are GPBAR1 agonists and can be used as medicaments for the treatment of diseases such as type II diabetes.

  这项发明涉及公式（I）中的新型苯基酰胺或吡啶基酰胺衍生物，其中A1、A2、B1、B2和R1至R11如描述和索赔中所定义，并且其药学上可接受的盐。这些化合物是GPBAR1激动剂，可用作治疗疾病如2型糖尿病的药物。
• 4-PHENOXY-NICOTINAMIDE OR 4-PHENOXY-PYRIMIDINE-5-CARBOXAMIDE COMPOUNDS
  申请人：Bissantz Caterina

  公开号：US20110178089A1

  公开（公告）日：2011-07-21

  This invention relates to novel phenyl amide or pyridyl amide derivatives of the formula wherein A 1 , A 2 , B 1 , B 2 and R 1 to R 11 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are GPBAR1 agonists and can be used as medicaments for the treatment of diseases such as type II diabetes.

  这项发明涉及公式的新型苯基酰胺或吡啶基酰胺衍生物 其中A 1 ，A 2 ，B 1 ，B 2 和R 1 到R 11 如描述和索赔中所定义，并且其药学上可接受的盐。这些化合物是GPBAR1激动剂，可用作治疗诸如2型糖尿病等疾病的药物。
• 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds
  申请人：Bissantz Caterina

  公开号：US08420647B2

  公开（公告）日：2013-04-16

  This invention relates to novel phenyl amide or pyridyl amide derivatives of the formula wherein A1, A2, B1, B2 and R1 to R11 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are GPBAR1 agonists and can be used as medicaments for the treatment of diseases such as type II diabetes.

  本发明涉及以下式子的新型苯酰胺或吡啶酰胺衍生物： 其中A1、A2、B1、B2和R1到R11如描述和权利要求中所定义，并且其药学上可接受的盐。这些化合物是GPBAR1激动剂，可用作治疗二型糖尿病等疾病的药物。
• Nucleic acid comprising zwitterionic nucleotides
  申请人：novosom AG

  公开号：EP2143726A1

  公开（公告）日：2010-01-13

  This invention provides pH-responsive zwitterionic nucleotides and nucleic acids comprising said nucleotides, wherein said zwitterions are constituted from one or more anionic internucleoside linkages and one or more cationic moieties and said zwitterionic nucleotides further comprise either one or more hydrophobic moieties or one or more TEE's with the general structure (I) Hydrophobic element - pH-responsive hydrophilic elements (I).

  本发明提供了 pH 响应型齐聚物核苷酸和包含所述核苷酸的核酸，其中所述齐聚物由一个或多个阴离子核苷内连接和一个或多个阳离子分子构成，所述齐聚物核苷酸进一步包含一个或多个疏水分子或一个或多个 TEE，其一般结构为 (I) 疏水元件--pH 响应亲水元件 (I)。
• VORONIN, V. G.;DOZOROVA, I. I.;ERMAKOVA, V. K.;KOLOSKOVA, L. I.;ALESHINA,+, KOMPLEKS. RAZRAB. TEXNOL. PR-BA SINTET. LEKARSTVEN. PREPARATOV, M.,(1988)+
  作者：VORONIN, V. G.、DOZOROVA, I. I.、ERMAKOVA, V. K.、KOLOSKOVA, L. I.、ALESHINA,+

  DOI：——

  日期：——